Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis

Cellular Signalling

Volumn 24, Issue 7, 2012, Pages 1406-1413

  Kim, Boh Ram ^a   Shin, Hye Jin ^a   Kim, Joo Young ^a   Byun, Hyun Jung ^a   Lee, Jeong Heon ^b   Sung, Young Kwan ^c   Rho, Seung Bae ^a  

^a National Cancer Center   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Apoptosis; CA9; DKK 1; Protein protein interaction; Tumorigenesis; Yeast two hybrid

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBONATE DEHYDRATASE IX; DICKKOPF 1 PROTEIN; FOCAL ADHESION KINASE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE; VALINE;

ANGIOGENESIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; FOCAL ADHESION KINASE 1; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860003307     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.03.002     Document Type: Article

References (57)

1. Giatromanolaki A., Koukourakis M.I., Sivridis E., Pastorek J., Wykoff C.C., Gatter K.C., Harris A.L. Cancer Res. 2001, 61:7992-7998.
2. Koukourakis M.I., Giatromanolaki A., Sivridis E., Simopoulos K., Pastorek J., Wykoff C.C., Gatter K.C., Harris A.L. Clin. Cancer Res. 2001, 7:3399-3403.
3. Cairns R., Papandreou I., Denko N. Mol. Cancer Res. 2006, 4:61-70.
4. Jubb A.M., Turley H., Moeller H.C., Steers G., Han C., Li J.L., Leek R., Tan E.Y., Singh B., Mortensen N.J., Noguera-Troise I., Pezzella F., Gatter K.C., Thurston G., Fox S.B., Harris A.L. Br. J. Cancer 2009, 101:1749-1757.
5. Nakamura J., Kitajima Y., Kai K., Hashiguchi K., Hiraki M., Noshiro H., Miyazaki K. Am. J. Pathol. 2011, 178:515-524.
6. Závada J., Závadová Z., Pastoreková S., Ciampor F., Pastorek J., Zelník V. Int. J. Cancer 1993, 54:268-274.
7. Pastorek J., Pastoreková S., Callebaut I., Mornon J.P., Zelník V., Opavský R. Oncogene 1994, 9:2877-2888.
8. Svastová E., Zilka N. Exp. Cell Res. 2003, 290:332-345.
9. Svastová E., Hulíková A., Rafajová M. FEBS Lett. 2004, 577:439-445.
10. Swietach P., Vaughan-Jones R.D., Harris A.L. Cancer Metastasis Rev. 2007, 26:299-310.
11. Morgan P.E., Pastoreková S., Stuart-Tilley A.K., Alper S.L., Casey J.R. Am. J. Physiol. Cell Physiol. 2007, 293:C738-C748.
12. Dorai T., Sawczuk I.S., Pastorek J., Wiernik P.H., Dutcher J.P. Eur. J. Cancer 2005, 41:2935-2947.
13. Folkman J., Shing Y. J. Biol. Chem. 1992, 267:10931-10934.
14. Risau W. Nature 1997, 386:671-674.
15. Ferrara N. Nat. Rev. Cancer 2002, 2:795-803.
16. Eferl R., Wagner E.F. Nat. Rev. Cancer 2003, 3:859-868.
17. Zhao T.T., Trinh D., Addison C.L., Dimitroulakos J. PLoS One 2010, 5:e12563.
18. Byrne A.M., Bouchier-Hayes D.J., Harmey J.H. J. Cell. Mol. Med. 2005, 9:777-794.
19. Strizzi L., Catalano A., Vianale G., Orecchia S., Casalini A., Tassi G., Puntoni R., Mutti L., Procopio A. J. Pathol. 2001, 193:468-475.
20. Glinka A., Wu W., Delius H., Monaghan A.P., Blumenstock C., Niehrs C. Nature 1998, 391:357-362.
21. Krupnik V.E., Sharp J.D., Jiang C., Robison K., Chickering T.W., Amaravadi L., Brown D.E., Guyot D., Mays G., Leiby K., Chang B., Duong T., Goodearl A.D., Gearing D.P., Sokol S.Y., McCarthy S.A. Gene 1999, 238:301-313.
22. Mukhopadhyay M., Shtrom S., Rodriguez-Esteban C., Chen L., Tsukui T., Gomer L., Dorward D.W., Glinka A., Grinberg A., Huang S.P., Niehrs C., Izpisúa Belmonte J.C., Westphal H. Dev. Cell 2001, 1:423-434.
23. Lee A.Y., He B., You L., Xu Z., Mazieres J., Reguart N., Mikami I., Batra S., Jablons D.M. Biochem. Biophys. Res. Commun. 2004, 323:1246-1250.
24. Mikheev A.M., Mikheeva S.A., Liu B., Cohen P., Zarbl H. Carcinogenesis 2004, 25:47-59.
25. Wirths O., Waha A., Weggen S., Schirmacher P., Kuhne T., Goodyer C.G., Albrecht S., Von Schweinitz D., Pietsch T. Lab. Invest. 2003, 83:429-434.
26. Gonzalez-Sancho J.M., Aguilera O., Garcia J.M., Pendas-Franco N., Pena C., Cal S., Garcia de Herreros A., Bonilla F., Munoz A. Oncogene 2005, 24:1098-1103.
27. Patil M.A., Chua M.S., Pan K.H., Lin R., Lih C.J., Cheung S.T., Ho C., Li R., Fan S.T., Cohen S.N., Chen X., So S. Oncogene 2005, 24:3737-3747.
28. Shin H.J., Rho S.B., Jung D.C., Han I.O., Oh E.S., Kim J.Y. J. Cell Sci. 2011, 124:1077-1087.
29. Rho S.B., Lee K.H., Kim J.W., Shiba K., Jo Y.J., Kim S. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10128-10133.
30. Lee O.H., Kim Y.M., Lee Y.M., Moon E.J., Lee D.J., Kim J.H., Kim K.W., Kwon Y.G. Biochem. Biophys. Res. Commun. 1999, 264:743-750.
31. Lee J.H., Chun T., Park S.Y., Rho S.B. Biochim. Biophys. Acta 2008, 783:1654-1662.
32. Van Nimwegen M.J., Van Dewater B. Biochem. Pharmacol. 2007, 73:597-609.
33. Morgan L., Nicholson R.I., Hiscox S. Endocr. Metab. Immune Disord. Drug Targets 2008, 8:273-278.
34. Schlessinger J. Cell 2000, 100:293-296.
35. Kanner S.B., Reynolds A.B., Vines R.R., Parsons J.T. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3328-3332.
36. Playford M.P., Schaller M.D. Oncogene 2004, 23:7928-7946.
37. McLean G.W., Avizienyte E., Frame M.C. Expert Opin. Pharmacother. 2003, 4:227-234.
38. Parsons J.T., Martin K.H., Slack J.K., Taylor J.M., Weed S.A. Oncogene 2000, 19:5606-5613.
39. Ilic D., Kovacic B., McDonagh S., Jin F., Baumbusch C., Gardner D.G., Damsky C.H. Circ. Res. 2003, 92:300-307.
40. Peng X., Ueda H., Zhou H., Stokol T., Shen T.L., Alcaraz A., Nagy T., Vassalli J.D., Guan J.L. Cardiovasc. Res. 2004, 64:421-430.
41. Kornberg L.J., Shaw L.C., Spoerri P.E., Caballero S., Grant M.B. Invest. Ophthalmol. Vis. Sci. 2004, 45:4463-4469.
42. Mitra S.K., Mikolon D., Molina J.E., Hsia D.A., Hanson D.A., Chi A., Lim S.T., Bernard-Trifilo J.A., Ilic D., Stupack D.G., Cheresh D.A., Schlaepfer D.D. Oncogene 2006, 25:5969-5984.
43. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., Liu E.T., Cance W.G. Cancer Res. 1995, 55:2752-2755.
44. Owens L.V., Xu L., Dent G.A., Yang X., Sturge G.C., Craven R.J., Cance W.G. Ann. Surg. Oncol. 1996, 3:100-105.
45. Judson P.L., He X., Cance W.G., Van Le L. Cancer 1999, 86:1551-1556.
46. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., Simkins S., Xu L. Clin. Cancer Res. 2000, 6:2417-2423.
47. Lark A.L., Livasy C.A., Calvo B., Caskey L., Moore D.T., Yang X., Cance W.G. Clin. Cancer Res. 2003, 9:215-222.
48. Lightfoot H.M., Jr A. Breast Cancer Res. Treat. 2004, 88:109-116.
49. Ocak S., Yamashita H., Udyavar A.R., Miller A.N., Gonzalez A.L., Zou Y., Jiang A., Yi Y., Shyr Y., Estrada L., Quaranta V., Massion P.P. Oncogene 2010, 29:6331-6342.
50. Yom C.K., Noh D.Y., Kim W.H., Kim H.S. Breast Cancer Res. Treat. 2011, 128:647-655.
51. Kumar C.C. Oncogene 1998, 17:1365-1373.
52. Xia C., Meng Q., Cao Z., Shi X., Jiang B.H. J. Cell. Physiol. 2006, 209:56-66.
53. Arbiser J.L., Kau T., Konar M., Narra K., Ramchandran R., Summers S.A., Vlahos C.J., Ye K., Perry B.N., Matter W., Fischl A., Cook J., Silver P.A., Bain J., Cohen P., Whitmire D., Furness S., Govindarajan B., Bowen J.P. Blood 2007, 109:560-565.
54. Jiang B.H., Liu L.Z. Biochim. Biophys. Acta 2008, 1784:150-158.
55. Duronio V., Scheid M.P., Ettinger S. Cell. Signal. 1998, 10:233-239.
56. Morgensztern D., McLeod H.L. Anticancer Drugs 2005, 16:797-803.
57. Sarbassov D.D., Ali S.M., Sabatini D.M. Curr. Opin. Cell Biol. 2005, 17:596-603.